Inhibition of Na +-H +exchange as a mechanism of rapid cardioprotection by resveratrol

British Journal of Pharmacology

Volumn 166, Issue 6, 2012, Pages 1745-1755

  Thuc, Luong Cong ^a   Teshima, Yasushi ^a   Takahashi, Naohiko ^a   Nishio, Satoru ^a   Fukui, Akira ^a   Kume, Osamu ^a   Saito, Shotaro ^a   Nakagawa, Mikiko ^a   Saikawa, Tetsunori ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Cardiomyocyte; Cardioprotection; Na + H + exchanger; PKC ; Resveratrol

Indexed keywords

CALCIUM ION; PROTEIN KINASE C ALPHA; REACTIVE OXYGEN METABOLITE; RESVERATROL; SODIUM ION;

ACIDIFICATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL PH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TRANSPORT; PROTON SODIUM EXCHANGE; RAT; REACTION TIME; REPERFUSION INJURY; WESTERN BLOTTING;

ANIMALS; CALCIUM; CARDIOTONIC AGENTS; CELLS, CULTURED; HEART VENTRICLES; HYDROGEN PEROXIDE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SODIUM; SODIUM-HYDROGEN ANTIPORTER; STILBENES; VENTRICULAR FUNCTION;

EID: 84863207184     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.01877.x     Document Type: Article

References (37)

1. Aiello EA, Cingolani HE (2011). A possible subcellular mechanism underlying the 'French paradox': the opening of mitochondrial KATP channels. Appl Physiol Nutr Metab 36: 768-772.
2. th Edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
3. Asensi M, Medina I, Ortega A, Carretero J, Bano MC, Obrador E et al. (2002). Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic Biol Med 33: 387-398. (Pubitemid 34786278)
4. Avkiran M, Marber MS (2002). Na+/H+ exchange inhibitors for cardioprotective therapy: progress, problems and prospects. J Am Coll Cardiol 39: 747-753. (Pubitemid 34185318)
5. Boyce SW, Bartels C, Bolli R, Chaitman B, Chen JC, Chi E et al. (2003). Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients: results of the CABG surgery cohort of the GUARDIAN study. J Thorac Cardiovasc Surg 126: 420-427. (Pubitemid 37048507)
6. Brookes PS (2004). Mitochondrial nitric oxide synthase. Mitochondrion 3: 187-204.
7. Chen CJ, Yu W, Fu YC, Wang X, Li JL, Wang W (2009). Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1-FoxO1 pathway. Biochem Biophys Res Commun 378: 389-393.
8. Cingolani HE, Ennis IL, Aiello EA, Perez NG (2011). Role of autocrine/paracrine mechanisms in response to myocardial strain. Pflugers Arch 462: 29-38.
9. Crompton M, Costi A, Hayat L (1987). Evidence for the presence of a reversible Ca2+-dependent pore activated by oxidative stress in heart mitochondria. Biochem J 245: 915-918.
10. Danz ED, Skramsted J, Henry N, Bennett JA, Keller RS (2009). Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway. Free Radic Biol Med 46: 1589-1597.
11. Das S, Alagappan VK, Bagchi D, Sharma HS, Maulik N, Das DK (2005). Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart. Vascul Pharmacol 42: 281-289. (Pubitemid 40726331)
12. Dekker LV, Leitges M, Altschuler G, Mistry N, McDermott A, Roes J et al. (2000). Protein kinase C-β contributes to NADPH oxidase activation in neutrophils. Biochem J 347: 285-289. (Pubitemid 30199068)
13. + exchanger-1 inhibitors decrease myocardial superoxide production via direct mitochondrial action. J Appl Physiol 105: 1706-1713.
14. Garciarena CD, Fantinelli JC, Caldiz CI, Chiappe de Cingolani G, Ennis IL, Perez NG et al. (2011). Myocardial reperfusion injury: reactive oxygen species vs. NHE-1 reactivation. Cell Physiol Biochem 27: 13-22.
15. Gordeeva AV, Zvyagilskaya RA, Labas YA (2003). Cross-talk between reactive oxygen species and calcium in living cells. Biochemistry (Mosc) 68: 1077-1080.
16. Hattori R, Otani H, Maulik N, Das DK (2002). Pharmacological preconditioning with resveratrol: role of nitric oxide. Am J Physiol Heart Circ Physiol 282: H1988-H1995. (Pubitemid 34663004)
17. 2 and caspases 3 and 6 in the absence of cell death. Int J Biochem Cell Biol 41: 945-956.
18. Knight DR, Smith AH, Flynn DM, MacAndrew JT, Ellery SS, Kong JX et al. (2001). A novel sodium-hydrogen exchanger isoform-1 inhibitor, zoniporide, reduces ischemic myocardial injury in vitro and in vivo. J Pharmacol Exp Ther 297: 254-259. (Pubitemid 32242585)
19. Kroemer G, Dallaporta B, Resche-Rigon M (1998). The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 60: 619-642. (Pubitemid 28157889)
20. Maly K, Strese K, Kampfer S, Ueberall F, Baier G, Ghaffari-Tabrizi N et al. (2002). Critical role of protein kinase C α and calcium in growth factor induced activation of the Na+/H+ exchanger NHE1. FEBS Lett 521: 205-210. (Pubitemid 34628486)
21. + exchange inhibition against ischemia/reperfusion injury. J Am Coll Cardiol 37: 957-963.
22. Mosca SM, Cingolani HE (2002). Cardioprotection from ischemia/reperfusion induced by red wine extract is mediated by KATP channels. J Cardiovasc Pharmacol 40: 429-437. (Pubitemid 34971360)
23. 2+ exchanger inhibitors in ischaemic/reperfused rat hearts. Br J Pharmacol 151: 963-978.
24. Ray PS, Maulik G, Cordis GA, Bertelli AA, Bertelli A, Das DK (1999). The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic Biol Med 27: 160-169. (Pubitemid 29353096)
25. + exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA. Circulation 101: 2902-2908.
26. + exchange in neonatal rat cardiac myocytes. Circ Res 82: 1053-1062.
27. + channels by protein kinase C. Circ Res 83: 110-114.
28. Scholz W, Albus U, Counillon L, Gogelein H, Lang HJ, Linz W et al. (1995). Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res 29: 260-268.
29. Slater SJ, Seiz JL, Cook AC, Stagliano BA, Buzas CJ (2003). Inhibition of protein kinase C by resveratrol. Biochim Biophys Acta 1637: 59-69. (Pubitemid 36071597)
30. + exchange by hydrogen peroxide in adult rat ventricular myocytes. Cardiovasc Res 53: 470-480.
31. + exchange inhibitor, inhibits the mitochondrial death pathway. Circulation 108: 2275-2281.
32. Thomas JA, Buchsbaum RN, Zimniak A, Racker E (1979). Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry 18: 2210-2218. (Pubitemid 9191034)
33. ATP channels-derived reactive oxygen species activate pro-survival pathway in pravastatin-induced cardioprotection. Apoptosis 15: 669-678.
34. Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK (2004). High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32: 1377-1382. (Pubitemid 39564557)
35. Yoshida K, Hirata T, Akita Y, Mizukami Y, Yamaguchi K, Sorimachi Y et al. (1996). Translocation of protein kinase C-α, δ and e isoforms in ischemic rat heart. Biochim Biophys Acta 1317: 36-44. (Pubitemid 26336593)
36. 2+ exchanger, on stunned myocardium in anesthetized dogs. J Anesth 19: 124-130.
37. Zweier JL, Talukder MA (2006). The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 70: 181-190.